|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication June 5, 2006.
Revised July 12, 2006.
Accepted for publication August 4, 2006.
The aryl hydrocarbon receptor (AhR) is a ligand-activated basic-helix-loop-helix (bHLH) transcription factor that binds polyaromatic hydrocarbons (PAH), such as dioxin, and mediates their toxicity. Binding of PAH to AhR in the cytoplasm triggers a poorly defined transformation step of the receptor into a nuclear transcription factor. In this study, we show that the calcium-dependent cysteine protease, calpain, plays a major role in the ligand-induced transformation and signaling of AhR. Fluorescence imaging measurements showed that TCDD treatment elevates intracellular calcium, providing the trigger for calpain activation, as measured towards BOC-LM-CMAC, a calpain-specific substrate. Inhibition of calpain activity by the MDL28170 blocked the TCDD-induced nuclear translocation of AhR in Hepa1c1c7 mouse hepatoma cell line. Treatment of the human metastatic breast carcinoma cell line MT-2 with MDL28170 and PD 150606, two calpain-selective inhibitors, completely abolished the TCDD-induced transactivation of AhR as assessed by transcription of CYP1A1 gene. Previous studies have established that following TCDD-induced transactivation, the AhR undergoes a massive depletion; we show here that selective calpain inhibitors can block this step, suggesting that the ligand-induced down-regulation of the AhR is calpain-dependent. The data presented support a major role for calpain in the AhR transformation, transactivation and subsequent down-regulation, and provide a possible explanation for many of the reported phenomena of ligand-independent activation of AhR.
Key words:
Regulation of gene expression, Regulation - transcriptional, Ah receptor
This article has been cited by other articles:
![]() |
P. Monteiro, D. Gilot, E. Le Ferrec, C. Rauch, D. Lagadic-Gossmann, and O. Fardel Dioxin-Mediated Up-Regulation of Aryl Hydrocarbon Receptor Target Genes Is Dependent on the Calcium/Calmodulin/CaMKI{alpha} Pathway Mol. Pharmacol., March 1, 2008; 73(3): 769 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Pollenz Comments on "Calpain Mediates the Dioxin-Induced Activation and Down-Regulation of the Aryl Hydrocarbon Receptor" Mol. Pharmacol., January 1, 2007; 71(1): 384 - 385. [Full Text] [PDF] |
||||
![]() |
S. E. Eltom and Y. Dale Response to Comments on "Calpain Mediates the Dioxin-Induced Activation and Down-Regulation of the Aryl Hydrocarbon Receptor" Mol. Pharmacol., January 1, 2007; 71(1): 386 - 387. [Full Text] [PDF] |
||||